Real-time enrollment status for this metabolic dysfunction-associated steatohepatitis (mash) clinical trial
Current Status
Recruiting
Checked: October 26, 2026 at 6:22 PM UTC
| NCT Number | NCT07631637 |
| Recruiting Status | Recruiting |
| Condition | Metabolic Dysfunction-Associated Steatohepatitis (MASH) |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 26, 2026 (18 hours ago) |
As of October 26, 2026: Clinical trial NCT07631637 is currently recruiting participants. This phase2 study for metabolic dysfunction-associated steatohepatitis (mash) is actively seeking new participants at 15 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07631637 is actively recruiting participants as of October 26, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07631637 was last updated 18 hours ago (October 26, 2026). HelloStudys verifies this status automatically.